After the EIC Summit 2025 and EIC Partners Day, it is a good time to reflect on the past year of ecosystem partnership with the European Innovation Council (EIC) for internationalisation. Looking back to 2023, when EIC decided to expand their EIC service catalogue with a new section focusing on internationalisation, inXso had the pleasure of joining as one of the first and few to focus exclusively on the healthcare sector.
Dedicated Programmes for EIC Beneficiaries
Supporting EIC Awardees and Seal of Excellence holders in their internationalisation efforts has been just a tiny part of the ever-evolving collaboration with the EIC, as the programme presents an exceptional platform to exchange insights and expertise within the ecosystem with some of the best innovators in Europe.
The extent of on-demand services provided by the EIC ecosystem is illustrated by initiatives such as the Tech2Market Venture Building programme, which focuses on leveraging research results to build ventures from viable business ideas, and the EIC Access+ call, created exclusively to accelerate Deep-Tech Innovations.
Within such programmes, inXso is dedicated on supporting EIC pathfinder, EIC transition, EIC accelerator, and EIC Seal of Excellence holders in realising their innovation paths and developing their businesses to be market-access ready in the highly regulated healthcare sector.
EIC beneficiaries have developed their R&D roadmaps and successfully navigated regulatory challenges while building sustainable financial models, all by utilising our unique interdisciplinary and international expertise
Backing Visionary Entrepreneurs
Since inXso is providing specific niche support focusing on the on-demand needs of the EIC beneficiary, the support may include grassroots essentials such as compiling technical documentation, ensuring ISO 13485:2016 compliance, designing clinical trials according to ISO 14155:2020, creating risk management plans according to ISO 14971:2019, and IEC 62366 ensuring usability in the process, to name a few.
On a higher level, EIC beneficiaries have ensured their investor readiness by creating additional assets through inXso’s technical assessment, building sustainable financial models and fundraising strategies through inXso’s business development insights, and developing regulatory roadmaps with viable reimbursement models to access international markets leveraging inXso’s international regulatory expertise.
Learning from the Best
Since emerging medical technologies are the cornerstone of inXso’s activities in our continuous and ever-evolving cooperation with research teams, helping EIC beneficiaries is one of the areas where we feel most comfortable.
At the same time, it has been a great pleasure to see and get to know the cream of the crop of innovations supported by the EIC ecosystem and to learn from the latest research.
Given the nature of emerging medical technologies, it is not a straightforward process to establish regulatory routes as, in many cases, the current regulatory framework does not cover the innovation – yet, since regulatory compliance is reactive in nature and evolves according to the latest research seeking its way to market.
However, precisely because of these challenges, nothing is as rewarding as seeing cutting-edge research reach healthcare providers and patients.
About inXso
Born internationally, we help innovators open new lines of research and technology that are disrupting existing healthcare ecosystems.
inXso is an innovation agency specialising in breakthrough, disruptive, and emerging technologies for healthcare, covering deep tech and nanotechnology solutions for medical, biomedical, and health technology. Following our motto, “We bridge the gap between medical research, the development of medical innovation, and international commercialisation”, we provide expertise in co-innovation and development, international business development, and innovation procurement support.
inXso provides services in the healthcare sector with three focus areas:
EIC Partner for Internationalisation
Get familiar with our support for internationalisation in the healthcare sector in the EIC Catalogue.
